Cardiovascular Prevention and the Implementation Gap in GLP-1 Receptor Agonist Therapies: After the Trials. Erhabor J, Silver N, Blaha MJ. J Am Coll Cardiol 2026;88:710-712.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Erhabor J, Silver N, Blaha MJ. Cardiovascular Prevention and the Implementation Gap in GLP-1 Receptor Agonist Therapies: After the Trials. J Am Coll Cardiol 2026;88:710-712.
PMID: 42583991